VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
PRICE: 0 CENTS
Friday, January 2, 2026
AMETEK, Inc.
AME · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
AMETEK is a diversified industrial technology company organized into two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). Its moat is built around engineered differentiation in targeted niche markets, sustained investment in R&D/engineering, and a company-wide Operational Excellence system that supports high margins and cash generation. EIG (about 67% of FY2024 sales) sells advanced analytical/test/measurement instruments; EMG (about 33%) sells precision motion control and other engineered electromechanical solutions including medical components and interconnects. Key risks include cyclicality in aerospace/industrial end-markets and execution/integration risk from ongoing acquisitions.
Primary segment
Electronic Instruments Group (EIG)
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
2 segments · 4 tags
Updated 2026-01-02
Segments
Electronic Instruments Group (EIG)
Advanced analytical, test and measurement instruments
Revenue
67.1%
Structure
Oligopoly
Pricing
strong
Share
—
Peers
Electromechanical Group (EMG)
Highly engineered electromechanical components (motion control, medical components, thermal management, interconnects)
Revenue
32.9%
Structure
Competitive
Pricing
moderate
Share
—
Peers
Moat Claims
Electronic Instruments Group (EIG)
Advanced analytical, test and measurement instruments
FY2024 segment revenue share is computed from reported net sales (EIG $4,659.9m; total $6,941.2m).
Capex Knowhow Scale
Supply
Capex Knowhow Scale
Strength
Durability
Confidence
Evidence
Engineering/R&D intensity and differentiated instrument design support leadership in niche measurement markets.
Erosion risks
- Technology shifts reduce differentiation
- R&D underinvestment vs peers
- Price competition in mature instrument categories
Leading indicators
- R&D/engineering spend and new-product vitality
- Segment operating margin trend
- Win rates in core niches
Counterarguments
- Instrumentation markets can be competitive with well-funded incumbents
- Some applications may tolerate lower-cost alternatives over time
Operational Excellence
Supply
Operational Excellence
Strength
Durability
Confidence
Evidence
Lean manufacturing and continuous-improvement playbook supports cost and cycle-time advantages, enabling sustained high margins.
Erosion risks
- Supply chain disruption or input inflation
- Execution drift across a large acquired portfolio
- Reshoring/regionalization increases costs
Leading indicators
- Cash conversion / working-capital turns
- Gross margin and lead-time metrics
- Backlog conversion and on-time delivery
Counterarguments
- Lean practices are widely adopted and can be matched
- Cost advantage may be competed away in price-sensitive bids
Scope Economies
Supply
Scope Economies
Strength
Durability
Confidence
Evidence
Acquisition integration and consolidation can create synergies in operations and distribution across a portfolio of niche businesses.
Erosion risks
- Overpaying for targets
- Integration complexity and culture mismatch
- Regulatory or financing constraints on M&A
Leading indicators
- Goodwill and acquired intangible growth vs organic growth
- Integration costs vs plan
- Post-deal margin trajectory
Counterarguments
- Acquisition-driven growth can mask weaker underlying demand
- Synergies can be one-time and harder to repeat at scale
Electromechanical Group (EMG)
Highly engineered electromechanical components (motion control, medical components, thermal management, interconnects)
FY2024 segment revenue share is computed from reported net sales (EMG $2,281.3m; total $6,941.2m).
Capex Knowhow Scale
Supply
Capex Knowhow Scale
Strength
Durability
Confidence
Evidence
Engineering-led differentiation in precision motion control, medical components and thermal/interconnect solutions supports niche positions.
Erosion risks
- Commoditization in components/interconnects
- Customer dual-sourcing and price-down demands
- Technology substitution in materials/processes
Leading indicators
- New product introduction cadence
- Mix shift toward higher-value engineered products
- Gross margin trend by end-market
Counterarguments
- Many component categories have numerous capable suppliers
- Large OEM customers can exert purchasing power
Operational Excellence
Supply
Operational Excellence
Strength
Durability
Confidence
Evidence
AMETEK's operational system (lean, sourcing, DFSS/VA-VE) is applied across EMG to drive cost discipline and integration benefits.
Erosion risks
- Integration costs persist longer than expected
- Supply chain shocks or labor constraints
- Complexity from portfolio breadth
Leading indicators
- Integration cost run-rate vs guidance
- Working capital efficiency
- On-time delivery and quality metrics
Counterarguments
- Cost programs may not offset pricing pressure in cyclical markets
- Operational advantages can be replicated by other global industrials
Scope Economies
Supply
Scope Economies
Strength
Durability
Confidence
Evidence
Serial M&A and portfolio integration can expand EMG's product breadth and create cross-selling/distribution and back-office synergies.
Erosion risks
- M&A multiple expansion reduces returns
- Customer/supplier disruption from integration
- Regulatory scrutiny in healthcare/aerospace
Leading indicators
- Goodwill and intangible asset growth vs cash flow
- Post-deal margin recovery
- Organic growth vs acquired growth
Counterarguments
- Cross-selling benefits are often overstated in industrial M&A
- Integration complexity increases with deal cadence
Evidence
technologically superior
The 10-K describes EIG products as often technologically superior and attributes competitive advantage to continued R&D/engineering investment.
lean manufacturing
The 10-K details AMETEK's Operational Excellence system (lean manufacturing, global sourcing, Design for Six Sigma) and claims it lowers costs, shortens cycle times and improves customer satisfaction.
30.7%
EIG FY2024 operating margin was 30.7% (operating income $1,428.4m on net sales $4,659.9m); used to support pricing power assessment and to compute segment revenue/profit shares.
operating synergies
The 10-K states acquisitions have enabled operating synergies via consolidation of operations, product lines and distribution channels.
technologically superior
The 10-K states EMG products are often significantly different from or technologically superior to competitors' and cites continued R&D/engineering investment as a driver of advantage.
Showing 5 of 8 sources.
Risks & Indicators
Erosion risks
- Technology shifts reduce differentiation
- R&D underinvestment vs peers
- Price competition in mature instrument categories
- Supply chain disruption or input inflation
- Execution drift across a large acquired portfolio
- Reshoring/regionalization increases costs
Leading indicators
- R&D/engineering spend and new-product vitality
- Segment operating margin trend
- Win rates in core niches
- Cash conversion / working-capital turns
- Gross margin and lead-time metrics
- Backlog conversion and on-time delivery
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.